Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P K Lemcke

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
European Journal of Pharmacology|January 25, 1991
Spinally mediated opioid antidiarrheal effectsP K Lemcke, J E Shook, T F Burks
Proceedings of the Western Pharmacology Society|January 1, 1989
RX809055AX in vivo: a long lasting opioid antagonist at mu and delta receptorsP K Lemcke, E A Ayres, T H Kramer, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1989
Antidiarrheal properties of supraspinal mu and delta and peripheral mu, delta and kappa opioid receptors: inhibition of diarrhea without constipationJ E Shook, P K Lemcke, C A Gehrig, et al.
Journal of Medicinal Chemistry|January 1, 1990
Assessment of the in vivo and in vitro opioid activity of bridged hexahydroaporphine and isoquinoline moleculesV F Roche, E B Roche, P K Lemcke, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1988
Opioid receptor selectivity of beta-endorphin in vitro and in vivo: mu, delta and epsilon receptorsJ E Shook, W Kazmierski, W S Wire, et al.
Proceedings of the Western Pharmacology Society|January 1, 1989
A comparison among antinociceptive bioassays for mu and delta agonistsE A Ayres, P K Lemcke, T H Kramer, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1987
Mu opioid antagonist properties of a cyclic somatostatin octapeptide in vivo: identification of mu receptor-related functionsJ E Shook, J T Pelton, P K Lemcke, et al.
NIDA Research Monograph|January 1, 1986
Comparison of the opioid antagonist properties of a cyclic somatostatin analog in vitro and in vivoJ E Shook, J T Pelton, W Kazmierski, et al.
NIDA Research Monograph|January 1, 1987
A cyclic somatostatin analog that precipitates withdrawal in morphine-dependent miceJ E Shook, J T Pelton, W Kazmierski, et al.
Proceedings of the Western Pharmacology Society|January 1, 1987
N-terminal cyclization of a nonsulfated CCK analogue exhibits opioid antagonist activity in vitroP K Lemcke, E Sugg, M Malarchik, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
European Journal of Pharmacology|January 25, 1991
Spinally mediated opioid antidiarrheal effectsP K Lemcke, J E Shook, T F Burks
Proceedings of the Western Pharmacology Society|January 1, 1989
RX809055AX in vivo: a long lasting opioid antagonist at mu and delta receptorsP K Lemcke, E A Ayres, T H Kramer, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1989
Antidiarrheal properties of supraspinal mu and delta and peripheral mu, delta and kappa opioid receptors: inhibition of diarrhea without constipationJ E Shook, P K Lemcke, C A Gehrig, et al.
Journal of Medicinal Chemistry|January 1, 1990
Assessment of the in vivo and in vitro opioid activity of bridged hexahydroaporphine and isoquinoline moleculesV F Roche, E B Roche, P K Lemcke, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1988
Opioid receptor selectivity of beta-endorphin in vitro and in vivo: mu, delta and epsilon receptorsJ E Shook, W Kazmierski, W S Wire, et al.
Proceedings of the Western Pharmacology Society|January 1, 1989
A comparison among antinociceptive bioassays for mu and delta agonistsE A Ayres, P K Lemcke, T H Kramer, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1987
Mu opioid antagonist properties of a cyclic somatostatin octapeptide in vivo: identification of mu receptor-related functionsJ E Shook, J T Pelton, P K Lemcke, et al.
NIDA Research Monograph|January 1, 1986
Comparison of the opioid antagonist properties of a cyclic somatostatin analog in vitro and in vivoJ E Shook, J T Pelton, W Kazmierski, et al.
NIDA Research Monograph|January 1, 1987
A cyclic somatostatin analog that precipitates withdrawal in morphine-dependent miceJ E Shook, J T Pelton, W Kazmierski, et al.
Proceedings of the Western Pharmacology Society|January 1, 1987
N-terminal cyclization of a nonsulfated CCK analogue exhibits opioid antagonist activity in vitroP K Lemcke, E Sugg, M Malarchik, et al.
Pageof 1